SEC Issues Accounting & Auditing Enforcement Order Involving DMK Pharmaceuticals, Robert O. Hopkins
January 16, 2025
January 16, 2025
WASHINGTON, Jan. 16 -- The Securities and Exchange Commission's Accounting and Auditing Enforcement issued the following order (No. 4555) on Jan. 14, 2025:
* * *
In the Matter of DMK PHARMACEUTICALS CORPORATION (f/k/a ADAMIS PHARMACEUTICALS CORPORATION) and ROBERT O. HOPKINS, Respondents.
ORDER INSTITUTING ADMINISTRATIVE AND CEASE-AND-DESIST PROCEEDINGS, PURSUANT TO SECTION 8A OF THE SECURITIES ACT OF 1933, SECTIONS 4C AND 21C OF THE SECURITIES EXCHANG . . .
* * *
In the Matter of DMK PHARMACEUTICALS CORPORATION (f/k/a ADAMIS PHARMACEUTICALS CORPORATION) and ROBERT O. HOPKINS, Respondents.
ORDER INSTITUTING ADMINISTRATIVE AND CEASE-AND-DESIST PROCEEDINGS, PURSUANT TO SECTION 8A OF THE SECURITIES ACT OF 1933, SECTIONS 4C AND 21C OF THE SECURITIES EXCHANG . . .